BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA). The systemic nature of CKD. Nat Rev Nephrol 2017;13:344-58. [PMID: 28435157 DOI: 10.1038/nrneph.2017.52] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 21.2] [Reference Citation Analysis]
Number Citing Articles
1 Noels H, Jankowski J. Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease". Toxins (Basel) 2020;12:E384. [PMID: 32545170 DOI: 10.3390/toxins12060384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bian X, Su X, Wang Y, Zhao G, Zhang B, Li D. Periostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: Reduction of PPARα. Biochimie 2019;160:172-82. [DOI: 10.1016/j.biochi.2019.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Bao JF, Hu PP, She QY, Li A. A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy. J Am Soc Nephrol 2020;31:1423-34. [PMID: 32527977 DOI: 10.1681/ASN.2020010081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
4 Wang HY, Meng Q, Yang C, Wang Y, Kong G, Zhao Y, Wang F, Zhang L. Association between pulse pressure, systolic blood pressure and the risk of rapid decline of kidney function among general population without hypertension: results from the China health and retirement longitudinal study (CHARLS). J Transl Med 2021;19:512. [PMID: 34930335 DOI: 10.1186/s12967-021-03176-8] [Reference Citation Analysis]
5 Hatamizadeh P. Cardiorenal Syndrome: An Important Subject in Nephrocardiology. Cardiol Clin 2021;39:455-69. [PMID: 34247758 DOI: 10.1016/j.ccl.2021.05.001] [Reference Citation Analysis]
6 Cardoso DF, Marques EA, Leal DV, Ferreira A, Baker LA, Smith AC, Viana JL. Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies. BMC Nephrol 2020;21:334. [PMID: 32770949 DOI: 10.1186/s12882-020-01999-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders H. Chronic kidney disease. Nat Rev Dis Primers 2017;3. [DOI: 10.1038/nrdp.2017.88] [Cited by in Crossref: 192] [Cited by in F6Publishing: 162] [Article Influence: 38.4] [Reference Citation Analysis]
8 Wu J, Dong J, Verzola D, Hruska K, Garibotto G, Hu Z, Mitch WE, Thomas SS. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk. J Cachexia Sarcopenia Muscle 2019;10:1210-27. [PMID: 31507080 DOI: 10.1002/jcsm.12459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Baragetti A, Ossoli A, Strazzella A, Simonelli S, Baragetti I, Grigore L, Pellegatta F, Catapano AL, Norata GD, Calabresi L. Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease. J Clin Med 2020;9:E2289. [PMID: 32708515 DOI: 10.3390/jcm9072289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Tøndel C, Marti HP. Cardiovascular changes in young renal failure patients. Clin Kidney J 2022;15:183-5. [PMID: 35145633 DOI: 10.1093/ckj/sfab223] [Reference Citation Analysis]
11 Bulbul M, Dagel T, Afsar B, Ulusu N, Kuwabara M, Covic A, Kanbay M. Disorders of Lipid Metabolism in Chronic Kidney Disease. Blood Purif 2018;46:144-52. [DOI: 10.1159/000488816] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
12 Copur S, Sag AA, Afsar B, Rossignol P, Covic A, Kanbay M. Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer. Int Urol Nephrol 2020;52:2311-20. [PMID: 32661618 DOI: 10.1007/s11255-020-02563-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins (Basel) 2018;10:E300. [PMID: 30029499 DOI: 10.3390/toxins10070300] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
14 Roumeliotis S, Mallamaci F, Zoccali C. Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. J Clin Med 2020;9:E2359. [PMID: 32718053 DOI: 10.3390/jcm9082359] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
15 Hu X, Xie Y, Xiao Y, Zeng W, Gong Z, Du J. Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model. Eur J Pharmacol 2020;886:173555. [PMID: 32937112 DOI: 10.1016/j.ejphar.2020.173555] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Hu X, Ouyang S, Xie Y, Gong Z, Du J. Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med 2020;132:495-505. [PMID: 32241215 DOI: 10.1080/00325481.2020.1744335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Mantovani A, Zusi C, Dalbeni A, Grani G, Buzzetti E. Risk of Kidney Dysfunction IN Nafld. CPD 2020;26:1045-61. [DOI: 10.2174/1381612825666191026113119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Lee Y, Park S, Lee S, Kim Y, Kang MW, Cho S, Park S, Han K, Kim YC, Han SS, Lee H, Lee JP, Joo KW, Lim CS, Kim YS, Kim DK. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study. PLoS One 2020;15:e0231328. [PMID: 32271842 DOI: 10.1371/journal.pone.0231328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Aycart DF, Acevedo S, Eguiguren-Jimenez L, Andrade JM. Influence of Plant and Animal Proteins on Inflammation Markers among Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Nutrients 2021;13:1660. [PMID: 34068841 DOI: 10.3390/nu13051660] [Reference Citation Analysis]
20 Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. Toxins (Basel) 2018;10:E33. [PMID: 29316724 DOI: 10.3390/toxins10010033] [Cited by in Crossref: 117] [Cited by in F6Publishing: 95] [Article Influence: 29.3] [Reference Citation Analysis]
21 Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation. Oxid Med Cell Longev 2021;2021:6651367. [PMID: 33628373 DOI: 10.1155/2021/6651367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
22 Mandai S, Ando F, Mori T, Susa K, Iimori S, Naito S, Sohara E, Uchida S, Fushimi K, Rai T. Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study. PLoS One 2021;16:e0258846. [PMID: 34731197 DOI: 10.1371/journal.pone.0258846] [Reference Citation Analysis]
23 Díez J, Ortiz A. The need for a cardionephrology subspecialty. Clin Kidney J 2021;14:1491-4. [PMID: 34276973 DOI: 10.1093/ckj/sfab054] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Wang HY, Ding GH, Lin H, Sun X, Yang C, Peng S, Wang J, Du J, Zhao Y, Chen Z, Bao B, Kong G, Zhang L. Influence of doctors' perception on the diagnostic status of chronic kidney disease: results from 976 409 individuals with electronic health records in China. Clin Kidney J 2021;14:2428-36. [PMID: 34754439 DOI: 10.1093/ckj/sfab089] [Reference Citation Analysis]
25 van Raaij S, van Swelm R, Bouman K, Cliteur M, van den Heuvel MC, Pertijs J, Patel D, Bass P, van Goor H, Unwin R, Srai SK, Swinkels D. Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease. Sci Rep 2018;8:9353. [PMID: 29921869 DOI: 10.1038/s41598-018-27107-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
26 Lu YA, Chen SW, Lee CC, Wu VC, Fan PC, Kuo G, Chen JJ, Chu PH, Chang SH, Chang CH. Mid-term survival of patients with chronic kidney disease after extracorporeal membrane oxygenation. Interact Cardiovasc Thorac Surg 2020;31:595-602. [PMID: 33005952 DOI: 10.1093/icvts/ivaa168] [Reference Citation Analysis]
27 Düsing P, Zietzer A, Goody PR, Hosen MR, Kurts C, Nickenig G, Jansen F. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl) 2021;99:335-48. [PMID: 33481059 DOI: 10.1007/s00109-021-02037-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Chade AR, Engel JE, Hall ME, Eirin A, Bidwell GL 3rd. INTRA-RENAL MODULATION OF NF-κB ACTIVITY ATTENUATES CARDIAC INJURY IN A SWINE MODEL OF CKD: A RENAL-CARDIO AXIS. Am J Physiol Renal Physiol 2021. [PMID: 34396789 DOI: 10.1152/ajprenal.00158.2021] [Reference Citation Analysis]
29 Arazi H, Mohabbat M, Saidie P, Falahati A, Suzuki K. Effects of Different Types of Exercise on Kidney Diseases. Sports 2022;10:42. [DOI: 10.3390/sports10030042] [Reference Citation Analysis]
30 Hung TV, Wanatanbe J, Yonejima Y, Hisa K, Yamamoto Y, Suzuki T. Exopolysaccharides from Leuconostoc mesenteroides attenuate chronic kidney disease in mice by protecting the intestinal barrier. Journal of Functional Foods 2019;52:276-83. [DOI: 10.1016/j.jff.2018.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
31 Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol 2019;15:87-108. [PMID: 30607032 DOI: 10.1038/s41581-018-0098-z] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 34.7] [Reference Citation Analysis]
32 Afsar B, Siriopol D, Aslan G, Eren OC, Dagel T, Kilic U, Kanbay A, Burlacu A, Covic A, Kanbay M. The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review. Int Urol Nephrol 2018;50:885-904. [DOI: 10.1007/s11255-018-1790-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
33 Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R; German COSYCONET consortium. Consequences of chronic kidney disease in chronic obstructive pulmonary disease. Respir Res 2019;20:151. [PMID: 31299972 DOI: 10.1186/s12931-019-1107-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
34 Schunk SJ, Floege J, Fliser D, Speer T. WNT-β-catenin signalling - a versatile player in kidney injury and repair. Nat Rev Nephrol 2021;17:172-84. [PMID: 32989282 DOI: 10.1038/s41581-020-00343-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
35 Blazquez-Navarro A, Dang-Heine C, Wehler P, Roch T, Bauer C, Neumann S, Blazquez-Navarro R, Kurchenko A, Wolk K, Sabat R, Westhoff TH, Olek S, Thomusch O, Seitz H, Reinke P, Hugo C, Sawitzki B, Or-Guil M, Babel N. Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre study. Transpl Int 2021;34:1680-8. [PMID: 34448272 DOI: 10.1111/tri.13982] [Reference Citation Analysis]
36 Shirani J, Meera S, Dilsizian V. The Cardiorenal Axis: Myocardial Perfusion, Metabolism, and Innervation. Curr Cardiol Rep 2019;21:60. [PMID: 31111315 DOI: 10.1007/s11886-019-1147-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
37 Mantovani A, Zusi C. PNPLA3 gene and kidney disease. Exploration of Medicine 2020;1:42-50. [DOI: 10.37349/emed.2020.00004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
38 El Amouri A, Snauwaert E, Foulon A, Vande Moortel C, Van Dyck M, Van Hoeck K, Godefroid N, Glorieux G, Van Biesen W, Vande Walle J, Raes A, Eloot S. Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain. Pediatr Nephrol 2021;36:1589-95. [PMID: 33387017 DOI: 10.1007/s00467-020-04840-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zannad F, Rossignol P. Cardiorenal Syndrome Revisited. Circulation 2018;138:929-44. [PMID: 30354446 DOI: 10.1161/CIRCULATIONAHA.117.028814] [Cited by in Crossref: 87] [Cited by in F6Publishing: 36] [Article Influence: 29.0] [Reference Citation Analysis]
40 Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation 2021;143:1157-72. [PMID: 33720773 DOI: 10.1161/CIRCULATIONAHA.120.050686] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
41 Bi X, Yang K, Zhang B, Zhao J. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease. Kidney Dis (Basel) 2020;6:395-406. [PMID: 33313060 DOI: 10.1159/000509369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Watanabe IKM, Andrade-Silva M, Foresto-Neto O, Felizardo RJF, Matheus MAC, Silva RC, Cenedeze MA, Honda TSB, Perandini LAB, Volpini RA, Pacheco-Silva A, Câmara NOS. Gut Microbiota and Intestinal Epithelial Myd88 Signaling Are Crucial for Renal Injury in UUO Mice. Front Immunol 2020;11:578623. [PMID: 33414781 DOI: 10.3389/fimmu.2020.578623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Câmara NOS. Inflammation in Renal Diseases: New and Old Players. Front Pharmacol 2019;10:1192. [PMID: 31649546 DOI: 10.3389/fphar.2019.01192] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 18.7] [Reference Citation Analysis]
44 Kanbay M, Tapoi L, Ureche C, Bulbul MC, Kapucu I, Afsar B, Basile C, Covic A. Coronary artery bypass grafting versus percutaneous coronary intervention in end-stage kidney disease: A systematic review and meta-analysis of clinical studies. Hemodial Int 2021. [PMID: 34085386 DOI: 10.1111/hdi.12946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Cheng Y, Chen Y, Wang G, Liu P, Xie G, Jing H, Chen H, Fan Y, Wang M, Zhou J. Protein Methylation in Diabetic Kidney Disease. Front Med 2022;9:736006. [DOI: 10.3389/fmed.2022.736006] [Reference Citation Analysis]
46 Yacoub R, Nadkarni GN, McSkimming DI, Chaves LD, Abyad S, Bryniarski MA, Honan AM, Thomas SA, Gowda M, He JC, Uribarri J. Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study. Exp Biol Med (Maywood) 2019;244:505-13. [PMID: 30539656 DOI: 10.1177/1535370218818175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
47 Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Monsalve M, Ramos AM, Sanchez-Niño MD, Ruiz-Ortega M, Ortiz A, Sanz AB. The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules 2020;10:E347. [PMID: 32102312 DOI: 10.3390/biom10020347] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
48 Sanchez-Niño MD, Fernandez-Fernandez B, Ortiz A. Klotho, the elusive kidney-derived anti-ageing factor. Clin Kidney J 2020;13:125-7. [PMID: 32297880 DOI: 10.1093/ckj/sfz125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
49 Jeon J, Jang HR, Huh W, Kim YG, Kim DJ, Lee JE. Predialysis predictors for identifying patients requiring dialysis at a higher glomerular filtration rate. Ren Fail 2021;43:1087-93. [PMID: 34219598 DOI: 10.1080/0886022X.2021.1940202] [Reference Citation Analysis]
50 Kumakura S, Nakamichi T, Suzuki N, Yamakage S, Ishikawa A, Fujikura E, Sato S, Aoki T, Musha H, Kikuchi K, Nagasawa T, Sato H, Ito S, Miyazaki M. A Catastrophic Case of Idiopathic Cholesterol Crystal Embolism with Multiple Lethal Complications: A Labyrinth Underneath the Diagnosis of Skin Ulcers in Chronic Kidney Disease Patients. Intern Med 2019;58:1753-8. [PMID: 30713332 DOI: 10.2169/internalmedicine.2378-18] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Cuarental L, Sucunza-sáenz D, Valiño-rivas L, Fernandez-fernandez B, Sanz AB, Ortiz A, Vaquero JJ, Sanchez-niño MD. MAP3K kinases and kidney injury. Nefrología (English Edition) 2019;39:568-80. [DOI: 10.1016/j.nefroe.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Deferrari G, Cipriani A, La Porta E. Renal dysfunction in cardiovascular diseases and its consequences. J Nephrol 2021;34:137-53. [PMID: 32870495 DOI: 10.1007/s40620-020-00842-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
53 Correale M, Paolillo S, Mercurio V, Limongelli G, Barillà F, Ruocco G, Palazzuoli A, Scrutinio D, Lagioia R, Lombardi C, Lupi L, Magrì D, Masarone D, Pacileo G, Scicchitano P, Matteo Ciccone M, Parati G, Tocchetti CG, Nodari S. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure. European Journal of Internal Medicine 2020;71:23-31. [DOI: 10.1016/j.ejim.2019.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
54 Loutradis C, Pitoulias AG, Pagkopoulou E, Pitoulias GA. Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients. Int Urol Nephrol 2021. [PMID: 34811606 DOI: 10.1007/s11255-021-03059-3] [Reference Citation Analysis]
55 Cuarental L, Sucunza-Sáenz D, Valiño-Rivas L, Fernandez-Fernandez B, Sanz AB, Ortiz A, Vaquero JJ, Sanchez-Niño MD. MAP3K kinases and kidney injury. Nefrologia (Engl Ed) 2019;39:568-80. [PMID: 31196660 DOI: 10.1016/j.nefro.2019.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
56 Williams J, Gilchrist M, Strain D, Fraser D, Shore A. The systemic microcirculation in dialysis populations. Microcirculation 2020;27:e12613. [PMID: 32065681 DOI: 10.1111/micc.12613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Li Y, Shen M, Ferens D, Broughton BRS, Murthi P, Saini S, Widdop RE, Ricardo SD, Pinar AA, Samuel CS. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension. Br J Pharmacol 2021;178:1164-81. [PMID: 33450051 DOI: 10.1111/bph.15361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G. Mild cognitive impairment and kidney disease: clinical aspects. Nephrol Dial Transplant 2020;35:10-7. [PMID: 31071220 DOI: 10.1093/ndt/gfz051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
59 Schunk SJ, Speer T, Petrakis I, Fliser D. Dickkopf 3-a novel biomarker of the 'kidney injury continuum'. Nephrol Dial Transplant 2021;36:761-7. [PMID: 32025732 DOI: 10.1093/ndt/gfaa003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
60 Seija M, Nin M, Santiago J, Apaza L, Castaño A, Poggi L, Urioste I, Chiossoni A, Fernandez A, Navarrine N, Garau M, Astesiano R, Ferrari MS, Noboa O. Being Overweight Is Related to Faster Decline in Annual Glomerular Filtration Rate in Kidney Transplant. Transplant Proc 2018;50:3392-6. [PMID: 30577211 DOI: 10.1016/j.transproceed.2018.04.040] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Kumakura S, Sato E, Sekimoto A, Hashizume Y, Yamakage S, Miyazaki M, Ito S, Harigae H, Takahashi N. Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease. Toxins (Basel) 2021;13:50. [PMID: 33440677 DOI: 10.3390/toxins13010050] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
62 Zeng M, Liu Y, Liu F, Peng Y, Sun L, Xiao L. Association between albumin-to-globulin ratio and long-term mortality in patients with chronic kidney disease: a cohort study. Int Urol Nephrol 2020;52:1103-15. [PMID: 32405697 DOI: 10.1007/s11255-020-02453-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Chang MS, Hsu YH. The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications. J Leukoc Biol 2018;104:919-23. [PMID: 29999545 DOI: 10.1002/JLB.MR1217-489R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
64 Campbell VK, Gately RP, Krishnasamy R, Burg D, Robertson GR, Gray NA. Midkine and chronic kidney disease-associated multisystem organ dysfunctions. Nephrol Dial Transplant 2021;36:1577-84. [PMID: 32542315 DOI: 10.1093/ndt/gfaa084] [Reference Citation Analysis]
65 Sarafidis P, Papadopoulos CE, Kamperidis V, Giannakoulas G, Doumas M. Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: A Milestone Achieved. Hypertension 2021;77:1442-55. [PMID: 33775130 DOI: 10.1161/HYPERTENSIONAHA.121.17005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Mazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, López-López D, Calvo-Lobo C, Rodríguez-Sanz D, Martínez-Jiménez EM, Palomo-López P. An Automated Blood Pressure Display for Self-Measurement in Patients With Chronic Kidney Disease (iHealth Track): Device Validation Study. JMIR Mhealth Uhealth 2020;8:e14702. [PMID: 32238337 DOI: 10.2196/14702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 De Santo NG. Nephrology a discipline evolving into complexity: between complex systems and philosophy. J Nephrol 2020;33:1-4. [PMID: 31776945 DOI: 10.1007/s40620-019-00674-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Wu M, Shu Y, Wang L, Song L, Chen S, Liu Y, Bi J, Li D, Yang Y, Hu Y, Wang Y, Wu S, Tian Y. Metabolic syndrome severity score and the progression of CKD. Eur J Clin Invest 2021;:e13646. [PMID: 34197633 DOI: 10.1111/eci.13646] [Reference Citation Analysis]
69 Alvarenga L, Cardozo LF, Borges NA, Lindholm B, Stenvinkel P, Shiels PG, Fouque D, Mafra D. Can nutritional interventions modulate the activation of the NLRP3 inflammasome in chronic kidney disease? Food Research International 2020;136:109306. [DOI: 10.1016/j.foodres.2020.109306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
70 Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, Pérez-Fernández M, Ortiz A. Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different? Arterioscler Thromb Vasc Biol 2019;39:1938-66. [PMID: 31412740 DOI: 10.1161/ATVBAHA.119.312705] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 14.3] [Reference Citation Analysis]
71 Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O’donnell D, Papi A, Pavord I, Roche N, Rodriguez-roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR. Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee. Annals ATS 2019;16:29-39. [DOI: 10.1513/annalsats.201808-557ps] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
72 Obara N, Inoue J, Endo H, Kakazu E, Ninomiya M, Iwata T, Sano A, Tsuruoka M, Masamune A. Spontaneous reactivation of hepatitis B virus with S gene mutations in an elderly patient with diabetic nephropathy. Clin J Gastroenterol 2020;13:914-9. [PMID: 32519312 DOI: 10.1007/s12328-020-01149-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Song X, Ji H, Li Y, Xiong Y, Qiu L, Zhong R, Tian M, Kizhakkedathu JN, Su B, Wei Q, Zhao W, Zhao C. Transient blood thinning during extracorporeal blood purification via the inactivation of coagulation factors by hydrogel microspheres. Nat Biomed Eng 2021. [PMID: 33495638 DOI: 10.1038/s41551-020-00673-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fliser D, Wanner C. Precision medicine in diabetic nephropathy and chronic kidney disease. Nephrol Dial Transplant 2021;36:10-3. [PMID: 34153982 DOI: 10.1093/ndt/gfaa380] [Reference Citation Analysis]
75 Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Godefroid N, Krid S, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Van Dyck M, Van Hoeck K, Collard L, Eloot S, Shroff R. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population. Toxins (Basel) 2019;11:E235. [PMID: 31022857 DOI: 10.3390/toxins11040235] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
76 Zoccali C, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Massy Z, Rychlık I, Jose Soler M, Stevens K, Spasovski G, Wanner C. Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials. Nephrol Dial Transplant 2019;34:1112-4. [PMID: 30815678 DOI: 10.1093/ndt/gfz023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
77 Wasiak S, Tsujikawa LM, Halliday C, Stotz SC, Gilham D, Jahagirdar R, Kalantar-Zadeh K, Robson R, Sweeney M, Johansson JO, Wong NC, Kulikowski E. Benefit of Apabetalone on Plasma Proteins in Renal Disease. Kidney Int Rep 2018;3:711-21. [PMID: 29854980 DOI: 10.1016/j.ekir.2017.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
78 Leader CJ, Wilkins GT, Walker RJ. The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat. PLoS One 2021;16:e0260554. [PMID: 34843581 DOI: 10.1371/journal.pone.0260554] [Reference Citation Analysis]
79 Kanbay M, Yerlikaya A, Sag AA, Ortiz A, Kuwabara M, Covic A, Wiecek A, Stenvinkel P, Afsar B. A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease. Clin Kidney J 2019;12:861-70. [PMID: 31807301 DOI: 10.1093/ckj/sfz106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 Bonacina F, Baragetti A, Catapano AL, Norata GD. The Interconnection Between Immuno-Metabolism, Diabetes, and CKD. Curr Diab Rep 2019;19:21. [PMID: 30888513 DOI: 10.1007/s11892-019-1143-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
81 Umbro I, Baratta F, Angelico F, Del Ben M. Nonalcoholic Fatty Liver Disease and the Kidney: A Review. Biomedicines 2021;9:1370. [PMID: 34680486 DOI: 10.3390/biomedicines9101370] [Reference Citation Analysis]
82 Marini AC, Pimentel GD. Is body weight or muscle strength correlated with the Malnutrition Inflammation Score (MIS)? A cross-sectional study in hemodialysis patients. Clinical Nutrition ESPEN 2019;33:276-8. [DOI: 10.1016/j.clnesp.2019.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
83 Gant CM, Minovic I, Binnenmars H, de Vries L, Kema I, van Beek A, Navis G, Bakker S, Laverman GD. Lower Renal Function Is Associated With Derangement of 11-β Hydroxysteroid Dehydrogenase in Type 2 Diabetes. J Endocr Soc 2018;2:609-20. [PMID: 29942925 DOI: 10.1210/js.2018-00088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Mawhin MA, Bright RG, Fourre JD, Vloumidi EI, Tomlinson J, Sardini A, Pusey CD, Woollard KJ. Chronic kidney disease mediates cardiac dysfunction associated with increased resident cardiac macrophages. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-021-02593-7] [Reference Citation Analysis]
85 Vanholder R, Annemans L, Bello AK, Bikbov B, Gallego D, Gansevoort RT, Lameire N, Luyckx VA, Noruisiene E, Oostrom T, Wanner C, Wieringa F. Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney. Clin Kidney J 2021;14:1719-30. [PMID: 34221379 DOI: 10.1093/ckj/sfab070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Cheddani L, Liabeuf S, Essig M, Snanoudj R, Jacquelinet C, Kerleau C, Metzger M, Balkau B, Drüeke TB, Hourmant M, Massy ZA; Nantes Kidney and Pancreas Transplantation Group and the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results. Nephrol Dial Transplant 2021;36:176-84. [PMID: 32162656 DOI: 10.1093/ndt/gfaa026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Bellini MI, Paoletti F, Herbert PE. Obesity and bariatric intervention in patients with chronic renal disease. J Int Med Res 2019;47:2326-41. [PMID: 31006298 DOI: 10.1177/0300060519843755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
88 Huang W, Isoherranen N. Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption. CPT Pharmacometrics Syst Pharmacol 2020;9:571-83. [PMID: 32977369 DOI: 10.1002/psp4.12553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Konrad L, Andersen K, Kesper MS, Kumar SV, Mulay SR, Anders H. The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis. Nephrology Dialysis Transplantation 2019. [DOI: 10.1093/ndt/gfz080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
90 Gan L, Yang B, Wang Y, Wang Y, Zuo L. COVID-19 Prevention and Control in Dialysis Centers during the Pandemic: A Single-Center Experience. Blood Purif 2021;:1-6. [PMID: 34038900 DOI: 10.1159/000515668] [Reference Citation Analysis]
91 Jerez-Morales A, Merino JS, Díaz-Castillo ST, Smith CT, Fuentealba J, Bernasconi H, Echeverría G, García-Cancino A. The Administration of the Synbiotic Lactobacillus bulgaricus 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model. Toxins (Basel) 2021;13:192. [PMID: 33800029 DOI: 10.3390/toxins13030192] [Reference Citation Analysis]
92 Kaneko K, Soty M, Zitoun C, Duchampt A, Silva M, Philippe E, Gautier-Stein A, Rajas F, Mithieux G. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting. Mol Metab 2018;16:203-12. [PMID: 29960865 DOI: 10.1016/j.molmet.2018.06.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
93 Vanholder R, Argilés A, Jankowski J; European Uraemic Toxin Work Group (EUTox) . A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox). Clin Kidney J 2021;14:1514-23. [PMID: 34413975 DOI: 10.1093/ckj/sfab011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
94 Parsegian K, Randall D, Curtis M, Ioannidou E. Association between periodontitis and chronic kidney disease. Periodontol 2000 2022. [PMID: 35244955 DOI: 10.1111/prd.12431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Matías-García P, Wilson R, Guo Q, Zaghlool S, Eales J, Xu X, Charchar F, Dormer J, Maalmi H, Schlosser P, Elhadad M, Nano J, Sharma S, Peters A, Fornoni A, Mook-Kanamori D, Winkelmann J, Danesh J, Di Angelantonio E, Ouwehand W, Watkins N, Roberts D, Petrera A, Graumann J, Koenig W, Hveem K, Jonasson C, Köttgen A, Butterworth A, Prunotto M, Hauck S, Herder C, Suhre K, Gieger C, Tomaszewski M, Teumer A, Waldenberger M. Plasma Proteomics of Renal Function: A Trans-ethnic Meta-analysis and Mendelian Randomization Study. J Am Soc Nephrol 2021:ASN. [PMID: 34135082 DOI: 10.1681/ASN.2020071070] [Reference Citation Analysis]
96 Lo LWT, Xu Y, Howe TS, Koh JSB, Lo NN, Yang YO. End stage renal disease patients undergoing hip fracture surgery have increased length of stay, acute hospital bill size, and reduced survivorship-implications on a bundled care program. Arch Osteoporos 2022;17:59. [PMID: 35385992 DOI: 10.1007/s11657-022-01103-y] [Reference Citation Analysis]
97 Zeng X, Hu Y, Chen Y, Lin Z, Liang Y, Liu B, Zhong P, Xiao Y, Li C, Wu G, Kong H, Du Z, Ren Y, Fang Y, Ye Z, Yang X, Yu H. Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients. Front Neurosci 2021;15:703898. [PMID: 34867144 DOI: 10.3389/fnins.2021.703898] [Reference Citation Analysis]
98 Zhang J, Chen H, Weng X, Liu H, Chen Z, Huang Q, Wang L, Liu X. RCAN1.4 attenuates renal fibrosis through inhibiting calcineurin-mediated nuclear translocation of NFAT2. Cell Death Discov 2021;7:317. [PMID: 34707090 DOI: 10.1038/s41420-021-00713-8] [Reference Citation Analysis]
99 Herder C, Hermanns N. Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes. Semin Immunopathol 2019;41:477-89. [PMID: 30778653 DOI: 10.1007/s00281-019-00730-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
100 Torino C, Pizzini P, Cutrupi S, Postorino M, Tripepi G, Mallamaci F, Reiser J, Zoccali C; PROGREDIRE Working Group. Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients. Kidney Int Rep 2018;3:1100-9. [PMID: 30197976 DOI: 10.1016/j.ekir.2018.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
101 Kreiner FF, Kraaijenhof JM, von Herrath M, Hovingh GKK, von Scholten BJ. Interleukin 6 in diabetes, chronic kidney disease and cardiovascular disease: mechanisms and therapeutic perspectives. Expert Rev Clin Immunol 2022. [PMID: 35212585 DOI: 10.1080/1744666X.2022.2045952] [Reference Citation Analysis]
102 Madduma Hewage S, Prashar S, Debnath SC, O K, Siow YL. Inhibition of Inflammatory Cytokine Expression Prevents High-Fat Diet-Induced Kidney Injury: Role of Lingonberry Supplementation. Front Med (Lausanne) 2020;7:80. [PMID: 32292787 DOI: 10.3389/fmed.2020.00080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
103 Buchanan S, Combet E, Stenvinkel P, Shiels PG. Klotho, Aging, and the Failing Kidney. Front Endocrinol (Lausanne) 2020;11:560. [PMID: 32982966 DOI: 10.3389/fendo.2020.00560] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
104 Chen JH, Chiang CK. Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence. Toxins (Basel) 2021;14:8. [PMID: 35050985 DOI: 10.3390/toxins14010008] [Reference Citation Analysis]
105 Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Saoussen K, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Shroff R, Eloot S. Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population. Nephrology Dialysis Transplantation 2020;35:648-56. [DOI: 10.1093/ndt/gfz132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
106 Gollie JM, Patel SS, Scholten JD, Harris-Love MO. Preliminary Study of the Effects of Eccentric-Overload Resistance Exercise on Physical Function and Torque Capacity in Chronic Kidney Disease. J Funct Morphol Kinesiol 2020;5:E97. [PMID: 33467312 DOI: 10.3390/jfmk5040097] [Reference Citation Analysis]
107 Sever MŞ, Jager KJ, Vanholder R, Stengel B, Harambat J, Finne P, Tesař V, Barbullushi M, Bumblytė IA, Zakharova E, Spasovski G, Resic H, Wiecek A, Blankestijn PJ, Bruchfeld A, Cozzolino M, Goumenos D, Soler MJ, Rychlík I, Stevens KI, Wanner C, Zoccali C, Massy ZA. A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community. Clin Kidney J 2021;14:23-35. [PMID: 33570513 DOI: 10.1093/ckj/sfaa218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
108 Ali BH, Al Za'abi M, Adham SA, Al Suleimani Y, Karaca T, Manoj P, Al Kalbani J, Yasin J, Nemmar A. The effect of sildenafil on rats with adenine-Induced chronic kidney disease. Biomed Pharmacother 2018;108:391-402. [PMID: 30236848 DOI: 10.1016/j.biopha.2018.09.061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
109 Bartoloni E, Alunno A, Gerli R. Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol 2018;15:33-44. [PMID: 28836617 DOI: 10.1038/nrcardio.2017.118] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
110 Bayes-Genis A, Bisbal F, Núñez J, Santas E, Lupón J, Rossignol P, Paulus W. Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach. J Clin Med 2020;9:E1110. [PMID: 32294958 DOI: 10.3390/jcm9041110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
111 Rao A, Ranka S, Ayers C, Hendren N, Rosenblatt A, Alger HM, Rutan C, Omar W, Khera R, Gupta K, Mody P, DeFilippi C, Das SR, Hedayati SS, de Lemos JA. Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. J Am Heart Assoc 2021;10:e020910. [PMID: 34107743 DOI: 10.1161/JAHA.121.020910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Apel C, Hornig C, Maddux FW, Ketchersid T, Yeung J, Guinsburg A. Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability. Clin Kidney J 2021;14:i98-i113. [PMID: 34987789 DOI: 10.1093/ckj/sfab193] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Zou D, Wu W, He Y, Ma S, Gao J. The role of klotho in chronic kidney disease. BMC Nephrol 2018;19:285. [PMID: 30348110 DOI: 10.1186/s12882-018-1094-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
114 Kanbay M, Yildiz AB, Yavuz F, Covic A, Ortiz A, Siriopol D. The role of body mass index on IgA nephropathy prognosis: a systematic review and meta-analysis. Int Urol Nephrol. [DOI: 10.1007/s11255-022-03160-1] [Reference Citation Analysis]
115 Forbes JM, Thorburn DR. Mitochondrial dysfunction in diabetic kidney disease. Nat Rev Nephrol 2018;14:291-312. [PMID: 29456246 DOI: 10.1038/nrneph.2018.9] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 29.0] [Reference Citation Analysis]
116 Mazzaferro S, De Martini N, Rotondi S, Tartaglione L, Ureña-Torres P, Bover J, Pasquali M; ERA-EDTA Working Group on CKD-MBD. Bone, inflammation and chronic kidney disease. Clin Chim Acta 2020;506:236-40. [PMID: 32275989 DOI: 10.1016/j.cca.2020.03.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
117 Hou YC, Fan YM, Huang YC, Chen RM, Wang CH, Lin YT, Yen TH, Lu KC, Lin YF. Tc-99m TRODAT-1 SPECT is a Potential Biomarker for Restless Leg Syndrome in Patients with End-Stage. J Clin Med 2020;9:E889. [PMID: 32213981 DOI: 10.3390/jcm9030889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Liu L, Zou J, Guan Y, Zhang Y, Zhang W, Zhou X, Xiong C, Tolbert E, Zhao TC, Bayliss G, Zhuang S. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition. FASEB J 2019;33:11941-58. [PMID: 31373855 DOI: 10.1096/fj.201801861R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
119 Yokoo K, Yamamoto Y, Suzuki T. Ammonia impairs tight junction barriers by inducing mitochondrial dysfunction in Caco-2 cells. FASEB J 2021;35:e21854. [PMID: 34597422 DOI: 10.1096/fj.202100758R] [Reference Citation Analysis]
120 Liu L, Liu F, Guan Y, Zou J, Zhang C, Xiong C, Zhao TC, Bayliss G, Li X, Zhuang S. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis. FASEB J 2021;35:e21715. [PMID: 34143514 DOI: 10.1096/fj.202000554RRR] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]